MedPath

A double-blind, randomized controlled trial of the effects of continuous intake of 1-kestose on defecation habits in children in kindergarte

Phase 2
Conditions
constipation
Registration Number
JPRN-UMIN000044252
Lead Sponsor
Center for Preventive Medical Sciences, Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who have a chronic illness and plan to start, end or change drug treatment during the trial period, or those who have a history of serious illness 2) Those who are allergic to test foods 3) Those who plan to start or end the intake of probiotics / prebiotics preparations or foods during the trial period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the number of defecation days per week (according to the questionnaire)
Secondary Outcome Measures
NameTimeMethod
Average number of defecation per week (according to a questionnaire) Fecal properties (by Bristol stool property scale / questionnaire) Changes in the intestinal flora in feces Changes in the number of copies of intestinal bacteria in feces Changes in short-chain fatty acids in feces Incidence of adverse events
© Copyright 2025. All Rights Reserved by MedPath